Heat-Killed Enterococcus faecalis EF-2001 Ameliorates Atopic Dermatitis in a Murine Model.

Area of Science:

• Immunology
• Microbiology
• Dermatology

Background:

• Atopic dermatitis (AD) is an allergic skin condition linked to immune dysregulation.
• Heat-killed lactic acid bacteria are known for their immunomodulatory properties.

Purpose of the Study:

• To evaluate the therapeutic effect of heat-killed Enterococcus faecalis EF-2001 (EF-2001) on atopic dermatitis.
• To investigate the immunomodulatory mechanisms of EF-2001 in an in vivo AD model.

Main Methods:

• An in vivo atopic dermatitis (AD) model was created in mice using Dermatophagoides farinae extract (DFE) and 2,4-dinitrochlorobenzene (DNCB).
• Mice were orally administered EF-2001 for four weeks, followed by measurements of ear thickness, mast cell infiltration, and serum immunoglobulin levels.
• Gene expression of pathogenic cytokines in the ears, lymph nodes, and splenocytes was analyzed.

Main Results:

• EF-2001 administration significantly attenuated AD symptoms, as evidenced by reduced ear thickness and improved histopathological findings.
• Serum immunoglobulin levels, particularly IgE, were reduced in EF-2001 treated mice.
• EF-2001 decreased the expression of key pathogenic cytokines induced by DFE/DNCB in various tissues and immune cells.

Conclusions:

• Heat-killed Enterococcus faecalis EF-2001 demonstrates significant therapeutic potential for treating atopic dermatitis.
• The immunomodulatory effects of EF-2001 contribute to its efficacy in alleviating AD symptoms and reducing inflammatory responses.